Clinical Trial Update: Expressive Writing in GVHD [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update reports that a Phase 1 early study examining expressive writing as an intervention for Graft Versus Host Disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: Northwestern University | Conditions: Graft Versus Host Disease | EARLY_Phase 1 | Status: TERMINATED